Vertebral Fracture Assessment by Dual-Energy X-ray Absorptiometry: Insurance Coverage Issues in the United States A White Paper of the International Society for Clinical Densitometry

Journal of Clinical Densitometry

Volumn 10, Issue 3, 2007, Pages 227-238

  Laster, Andrew J ^a   Lewiecki, E Michael ^b  

^a Arthritis and Osteoporosis Consultants of the Carolinas   (United States)

^b NEW MEXICO CLINICAL RESEARCH AND OSTEOPOROSIS CENTER   (United States)

Author keywords

Coverage; DXA; insurance; osteoporosis; payment; reimbursement; vertebral fracture; VFA

Indexed keywords

ALENDRONIC ACID; ETIDRONIC ACID; PLACEBO; RALOXIFENE; RISEDRONIC ACID;

ARTICLE; BACKACHE; BONE DENSITOMETRY; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; HEALTH CARE PERSONNEL; HUMAN; INTERMETHOD COMPARISON; MEDICAL INFORMATION SYSTEM; MEDICARE; OSTEOPENIA; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; SPINE RADIOGRAPHY; UNITED STATES; VERTEBRA FRACTURE;

ABSORPTIOMETRY, PHOTON; BONE DISEASES, METABOLIC; FEMALE; HUMANS; INSURANCE CLAIM REVIEW; INSURANCE COVERAGE; INSURANCE, HEALTH; POSTMENOPAUSE; SPINAL FRACTURES; UNITED STATES;

EID: 34547570929     PISSN: 10946950     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocd.2007.04.002     Document Type: Article

References (90)

1. Lewis M.K., Blake G.M., and Fogelman I. Patient dose in dual x-ray absorptiometry. Osteoporos Int 4 (1994) 11-15
2. Genant H.K., Engelke K., Fuerst T., et al. Noninvasive assessment of bone mineral and structure: state of the art. J Bone Miner 11 (1996) 707-730
3. Description of BCBS TEC. Blue Cross Blue Shield Association [serial online]. Available at:. www.bcbs.com/tec/whatistec.html Accessed August 27, 2006
4. BCBSA TEC. Vertebral assessment using dual-energy x-ray absorptiometry for osteoporotic fracture risk assessment. BCBSA TEC Assessment Program [serial online]. Available at: (2004). http://www.bcbs.com/tec/vol19/19_14.html Accessed: June 14, 2007
5. BCBSA TEC. Screening for vertebral fracture with dual x-ray absorptiometry. BCBSA TEC Assessment Program [serial online]. Available at: (2006). http://www.bcbs.com/tec/vol20/20_14.html Accessed: June 14, 2007
6. Denial of coverage for VFA by Aetna. Aetna Healthcare web site [serial online]. Available at:. http://www.aetna.com/cpb/data/CPBA0134.html Accessed August 24, 2006
7. Trailblazer denial of coverage for VFA. Trailblazer web site [serial online]. Available at:. http://www.trailblazerhealth.com/draftindex.asp?ID=265 Accessed August 23, 6 A.D.
8. Palmetto GBA coverage of VFA. Palmetto GBA web site [serial online]. Available at:. http://www.cms.hhs.gov/mcd/viewlcd.asp?lcd_id=5787&;lcd_version=22&basket=lcd%3A5787%3A22%3ABONE±MASS±MEASUREMENT%3ACarrier%3APalmetto±GBA±%2800880%29%3A Accessed August 24, 2006
9. FCSO coverage policy of VFA. First Coast Service Option web site [serial online] Available at:. www.floridamedicare.com Accessed August 23, 2006
10. Vokes T., Bachman D., Baim S., et al. Vertebral fracture assessment: the 2005 ISCD Official Positions. J Clin Densitom 9 (2006) 37-46
11. Riggs B.L., and Melton III L.J. The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone 17 Suppl (1995) S505-S511
12. Melton III L.J., Kan S.H., Frye M.A., Wahner H.W., O'Fallon W.M., and Riggs B.L. Epidemiology of vertebral fractures in women. Am J Epidemiol 120 (1989) 1000-1011
13. Kanis J.A., Johnell O., Oden A., et al. The risk and burden of vertebral fractures in Sweden. Osteoporos Int 15 1 (2004) 20-26
14. Ettinger B., Black D.M., Nevitt M.C., et al. Contribution of vertebral deformities to chronic back pain and disability. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res 7 (1992) 449-456
15. Silverman S.L. The clinical consequences of vertebral compression fracture. Bone 13 Suppl 2 (1992) S27-S31
16. Nevitt M.C., Ettinger B., Black D.M., et al. The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med 128 (1998) 793-800
17. Lyles K.W., Gold D.T., Shipp K.M., Pieper C.F., Martinez S., and Mulhausen P.L. Association of osteoporotic vertebral compression fractures with impaired functional status. Am J Med 94 (1993) 595-601
18. Ensrud K.E., Thompson D.E., Cauley J.A., et al. Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. Fracture Intervention Trial Research Group. J Am Geriatr Soc 48 (2000) 241-249
19. Johnell O., Kanis J.A., Oden A., et al. Mortality after osteoporotic fractures. Osteoporos Int 15 1 (2004) 38-42
20. Kado D.M., Browner W.S., Palermo L., Nevitt M.C., Genant H.K., and Cummings S.R. Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group. Arch Intern Med 159 (1999) 1215-1220
21. Black D.M., Arden N.K., Palermo L., Pearson J., and Cummings S.R. Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group. J Bone Miner Res 14 (1999) 821-828
22. Melton III L.J., Atkinson E.J., Cooper C., O'Fallon W.M., and Riggs B.L. Vertebral fractures predict subsequent fractures. Osteoporos Int 10 (1999) 214-221
23. Ross P.D., Davis J.W., Epstein R.S., and Wasnich R.D. Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med 114 (1991) 919-923
24. Ross P.D., Genant H.K., Davis J.W., Miller P.D., and Wasnich R.D. Predicting vertebral fracture incidence from prevalent fractures and bone density among non-black, osteoporotic women. Osteoporos Int 3 (1993) 120-126
25. Lindsay R., Silverman S.L., Cooper C., et al. Risk of new vertebral fracture in the year following a fracture. JAMA 285 (2001) 320-323
26. Lunt M., O'Neill T.W., Felsenberg D., et al. Characteristics of a prevalent vertebral deformity predict subsequent vertebral fracture: results from the European Prospective Osteoporosis Study (EPOS). Bone 33 (2003) 505-513
27. Gallagher J.C., Genant H.K., Crans G.G., Vargas S.J., and Krege J.H. Teriparatide reduces the fracture risk associated with increasing number and severity of osteoporotic fractures. J Clin Endocrinol Metab 90 (2005) 1583-1587
28. Delmas P.D., Genant H.K., Crans G.G., et al. Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial. Bone 33 (2003) 522-532
29. Pongchaiyakul C., Nguyen N.D., Jones G., Center J.R., Eisman J.A., and Nguyen T.V. Asymptomatic vertebral deformity as a major risk factor for subsequent fractures and mortality: a long-term prospective study. J Bone Miner Res 20 (2005) 1349-1355
30. World Health Organization. Assessment of fracture risk and its application to screening for post menopausal osteoporosis (1994), World Health Organization, Geneva, Switzerland
31. NIH Consensus Development Panel on Osteoporosis. JAMA 285 (2001) 785-795
32. Pasco J.A., Seeman E., Henry M.J., Merriman E.N., Nicholson G.C., and Kotowicz M.A. The population burden of fractures originates in women with osteopenia, not osteoporosis. Osteoporos Int (2006) 1-6
33. Black D.M., Cummings S.R., Karpf D.B., et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 348 (1996) 1535-1541
34. Chesnut III C.H., Silverman S., Andriano K., et al. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group. Am J Med 109 (2000) 267-276
35. Ettinger B., Black D.M., Mitlak B.H., et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 282 (1999) 637-645
36. Harris S.T., Watts N.B., Genant H.K., et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA 282 (1999) 1344-1352
37. Reginster J., Minne H.W., Sorensen O.H., et al. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int 11 (2000) 83-91
38. Neer R.M., Arnaud C.D., Zanchetta J.R., et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344 (2001) 1434-1441
39. Kanis J.A., Barton I.P., and Johnell O. Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture. Osteoporos Int 16 (2005) 475-482
40. Quandt S.A., Thompson D.E., Schneider D.L., Nevitt M.C., and Black D.M. Effect of alendronate on vertebral fracture risk in women with bone mineral density T scores of -1.6 to -2.5 at the femoral neck: the Fracture Intervention Trial. Mayo Clin Proc 80 (2005) 343-349
41. Stock J.L. Lilly/Data on file (2005)
42. Fletcher H. Anterior vertebral wedging: frequency and significance. AJR 57 (1947) 232-238
43. Barnett E., and Nordin B.E. The radiological diagnosis of osteoporosis: a new approach. Clin Radiol 11 (1960) 166-174
44. Hurxthal L.M. Measurement of anterior wedging vertebral compressions and biconcave vertebrae. AJR 103 (1968) 635-644
45. Smith Jr. R.W., Eyeler W.R., and Mellinger R.C. On the incidence of senile osteoporosis. Ann Intern Med 52 (1960) 773-781
46. Minne H.W., Leidig G., Wuster C., et al. A newly developed spine deformity index (SDI) to quantitate vertebral crush fractures in patients with osteoporosis. Bone Miner 3 (1988) 335-349
47. Black D.M., Cummings S.R., Stone K., Hudes E., Palermo L., and Steiger P. A new approach to defining normal vertebral dimensions. J Bone Miner Res 6 (1991) 883-892
48. Eastell R., Cedel S.L., Wahner H.W., Riggs B.L., and Melton III L.J. Classification of vertebral fractures. J Bone Miner Res 6 (1991) 207-215
49. McCloskey E.V., Spector T.D., Eyres K.S., et al. The assessment of vertebral deformity: a method for use in population studies and clinical trials. Osteoporos Int 3 (1993) 138-147
50. Genant H.K., Wu C.Y., van K.C., and Nevitt M.C. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8 (1993) 1137-1148
51. Gehlbach S.H., Bigelow C., Heimisdottir M., May S., Walker M., and Kirkwood J.R. Recognition of vertebral fracture in a clinical setting. Osteoporos Int 11 (2000) 577-582
52. Majumdar S.R., Kim N., Colman I., et al. Incidental vertebral fractures discovered with chest radiography in the emergency department: prevalence, recognition, and osteoporosis management in a cohort of elderly patients. Arch Intern Med 165 (2005) 905-909
53. Delmas P.D., van de L.L., Watts N.B., et al. Underdiagnosis of vertebral fractures is a worldwide problem: the IMPACT study. J Bone Miner Res 20 (2005) 557-563
54. Lenchik L., Rogers L.F., Delmas P.D., and Genant H.K. Diagnosis of osteoporotic vertebral fractures: importance of recognition and description by radiologists. AJR Am J Roentgenol 183 (2004) 949-958
55. Li J., Wu C.Y., and Jergas M. Vertebral fracture in osteoporosis. In: Genant H.K., Jergas M., and van Kuijk C. (Eds) (1995), University of California, San Francisco, CA 271-279
56. Wu C.Y., Li J., Jergas M., and Genant H.K. Comparison of semiquantitative and quantitative techniques for the assessment of prevalent and incident vertebral fractures. Osteoporos Int 5 (1995) 354-370
57. Fechtenbaum J., Cropet C., Kolta S., Verdoncq B., Orcel P., and Roux C. Reporting of vertebral fractures on spine X-rays. Osteoporos Int 16 (2005) 1823-1826
58. Genant H. International Osteoporosis Foundation, European Society of Musculoskeletal Radiology Osteoporosis: recognising and reporting vertebral fractures. International Osteoporosis Foundation. [serial online]. Available at:. http://www.osteofound.org/health_professionals/vfi/assets/resources/Summary-Handout-en.pdf Accessed August 29, 2006
59. Ferrar L., Jiang G., Eastell R., and Peel N.F. Visual identification of vertebral fractures in osteoporosis using morphometric X-ray absorptiometry. J Bone Miner Res 18 (2003) 933-938
60. Schousboe J.T., and Debold C.R. Reliability and accuracy of vertebral fracture assessment with densitometry compared to radiography in clinical practice. Osteoporos Int 17 (2006) 281-289
61. Rea J.A., Chen M.B., Li J., et al. Morphometric X-ray absorptiometry and morphometric radiography of the spine: a comparison of prevalent vertebral deformity identification. J Bone Miner Res 15 (2000) 564-574
62. Rea J.A., Li J., Blake G.M., Steiger P., Genant H.K., and Fogelman I. Visual assessment of vertebral deformity by X-ray absorptiometry: a highly predictive method to exclude vertebral deformity. Osteoporos Int 11 (2000) 660-668
63. Binkley N., Krueger D., Gangnon R., Genant H.K., and Drezner M.K. Lateral vertebral assessment: a valuable technique to detect clinically significant vertebral fractures. Osteoporos Int 16 (2005) 1513-1518
64. Schousboe J.T., Debold C.R., Bowles C., Glickstein S., and Rubino R.K. Prevalence of vertebral compression fracture deformity by X-ray absorptiometry of lateral thoracic and lumbar spines in a population referred for bone densitometry. J Clin Densitom 5 (2002) 239-246
65. Clark K.C. Positioning in radiography (1986), Butterworth-Heinemanns, Oxford, UK
66. van der Klift M., de Laet C.E., McCloskey E.V., Hofman A., and Pols H.A. The incidence of vertebral fractures in men and women: the Rotterdam Study. J Bone Miner Res 17 (2002) 1051-1056
67. Wu C., Genant H.K., von Ingersleben G., et al. Validation of lateral DXA imaging for assessment of vertebral fractures. J Bone Miner Res 19 Suppl 1 (2004) S295
68. Vokes T.J., Dixon L.B., and Favus M.J. Clinical utility of dual-energy vertebral assessment (DVA). Osteoporos Int 14 (2003) 871-878
69. Genant H.K., Mitlak B.H., Myers S., and Wang O. Radiographic fracture grade is related to clinical disease severity. Results from the rhPTH (1-34) fracture prevention study. Arthritis Rheum 43 (2000) S383
70. Jacobs-Kosmin D., Sandorfi N., Murray H., and Abruzzo J.L. Vertebral deformities identified by vertebral fracture assessment: associations with clinical characteristics and bone mineral density. J Clin Densitom 8 (2005) 267-272
71. Pavlov L., Gamble G.D., and Reid I.R. Comparison of dual-energy X-ray absorptiometry and conventional radiography for the detection of vertebral fractures. J Clin Densitom 8 (2005) 379-385
72. McClung M. Osteopenia: to treat or not to treat?. Ann Intern Med 142 (2005) 796-797
73. Management of postmenopausal osteoporosis: position statement of the North American Menopause Society. Menopause 9 (2002) 84-101
74. National Osteoporosis Foundation. 2003 Physician's Guide to prevention and treatment of osteoporosis. Washington, DC.
75. Hodgson S.F., Watts N.B., Bilezikian J.P., et al., AACE Osteoporosis Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis. Endocr Pract 9 (2003) 544-564
76. Delmas P., Rizzoli R., Cooper C., and Reginster J.-Y. Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation. Osteoporos Int 16 (2005) 1-5
77. Greenspan S.L., von S.E., Emond S.K., Jones L., and Parker R.A. Instant vertebral assessment: a noninvasive dual X-ray absorptiometry technique to avoid misclassification and clinical mismanagement of osteoporosis. J Clin Densitom 4 (2001) 373-380
78. Greenblatt D., Jones L.A., and Wilson K.E. Use of instant vertebral assessment in an internal medicine practice. J Bone Miner Res 17 (2002) S640
79. Nattrass S.M., Jones L.A., Kelly T.L., von Stetten E., and Wilson K.E. Vertebral fractures identified by IVA in postmenopausal women. J Bone Miner Res 16 S1 (2001) S515
80. Cheung A.M., Sinclair H., Lee Y., Hu H., Scher J., and Djokoto Hawker G. Prevalence of vertebral compression deformities in a population of healthy postmenopausal women with osteopenia-data from the ECKO trial. J Clin Densitom 9 2 (2006) Poster 173 ISCD San Diego 2006
81. Wainwright S.A., Marshall L.M., Ensrud K.E., et al., Orwoll ES for the Study of Osteoporotic Fractures Research Group. Hip fracture in women without osteoporosis. J Clin Endocrinol Metab 90 (2005) 2787-2793
82. Sornay-Rendu E., Munoz F., Garnero P., Duboeuf F., and Delmas P.D. Identification of osteopenic women at high risk of fracture: the OFELY study. J Bone Miner Res 20 (2005) 1813-1819
83. Cranney A., Guyatt G., Griffith L., Wells G., Tugwell P., Rosen C., and The Osteoporosis Methodology Group. Summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev 23 4 (2002) 570-578
84. Chesnut III C.H., Skag A., Christiansen C., et al. Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res 19 (2004) 1241-1249
85. Schousboe J.T., Nyman J.A., Kane R.L., and Ensrud K.E. Cost-effectiveness of alendronate therapy for osteopenic postmenopausal women. Ann Intern Med 142 (2005) 734-741
86. Schousboe J.T., Ensrud K.E., Nyman J.A., Kane R.L., and Melton III L.J. Cost-effectiveness of vertebral fracture assessment to detect prevalent vertebral deformity and select postmenopausal women with a femoral neck T-score > -2.5 for alendronate therapy: a modeling study. J Clin Densitom 9 (2006) 133-143
87. Newman E.D., Olenginski T.P., Perruquet J.L., and Hummer M. Vertebral fracture analysis using DXA-a clinically important and inexpensive method to improve osteoporosis risk stratification. Arthritis Rheum 52 Suppl (2005) 1833
88. Siminoski K., Warshawski R.S., Jen H., and Lee K. The accuracy of historical height loss for the detection of vertebral fractures in postmenopausal women. Osteoporos Int 17 (2006) 290-296
89. Siminoski K., Jiang G., Adachi J.D., et al. Accuracy of height loss during prospective monitoring for detection of incident vertebral fractures. Osteoporos Int 16 (2005) 403-410
90. Vogt T.M., Ross P.D., Palermo L., et al. Vertebral fracture prevalence among women screened for the Fracture Intervention Trial and a simple clinical tool to screen for undiagnosed vertebral fractures. Fracture Intervention Trial Research Group. Mayo Clin Proc 75 (2000) 888-896